Skip to main content

. 1994 Aug 15;151(4):441–443.

Amyotrophic lateral sclerosis: is excitotoxicity the key?

PMCID: PMC1337096 PMID: 8055404

441

Images in this article

Fig. 1
on p.442

Fig. 2
on p.443

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994 Mar 3;330(9):585–591. doi: 10.1056/NEJM199403033300901. [DOI] [PubMed] [Google Scholar]
Eisen A., Krieger C. Pathogenic mechanisms in sporadic amyotrophic lateral sclerosis. Can J Neurol Sci. 1993 Nov;20(4):286–296. [PubMed] [Google Scholar]
Krieger C., Wagey R., Lanius R. A., Shaw C. A. Activation of PKC reverses apparent NMDA receptor reduction in ALS. Neuroreport. 1993 Jul;4(7):931–934. doi: 10.1097/00001756-199307000-00023. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (912.7 KB)

RESOURCES